Gilead Sciences (GILD) Misses Q2 EPS by 34c; Guides In-Line
Tweet
Share
E-mail
Get Alerts GILD Hot Sheet
Price: $134.55 -0.94%
EPS Growth %: -464.2%
Financial Fact:
Provision for income taxes: 951M
Today's EPS Names:
CCEL, SLP, TMQ, More
EPS Growth %: -464.2%
Financial Fact:
Provision for income taxes: 951M
Today's EPS Names:
CCEL, SLP, TMQ, More
Join SI Premium – FREE
Gilead Sciences (NASDAQ: GILD) reported Q2 EPS of $1.11, $0.34 worse than the analyst estimate of $1.45. Revenue for the quarter came in at $5.1 billion versus the consensus estimate of $5.31 billion.
GUIDANCE:
Gilead Sciences sees FY2020 EPS of $6.25-$7.65, versus the consensus of $6.71. Gilead Sciences sees FY2020 revenue of $23-25 billion, versus the consensus of $23.44 billion.
For earnings history and earnings-related data on Gilead Sciences (GILD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- HSBC Upgrades Gilead Sciences (GILD) to Buy
- Applied Materials surges as CEO signals multi-year chip boom
- Penguin Solutions (PENG) Tops Q2 EPS by 28c, Beats on Revenue; Offers FY26 EPS Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
